JPMorgan Reinstates Vertex (VRTX) at Overweight

JPMorgan analyst Jessica Fye reinstates coverage on Vertex (NASDAQ: VRTX) with a Overweight rating and a price target of $515.00.

For an analyst ratings summary and ratings history on Vertex click here. For more ratings news on Vertex click here.

Shares of Vertex closed at $434.31 yesterday.

You May Also Be Interested In

• Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5–11, at the European Hematology Association Congress and Announces Additional Global Regulatory
• Macquarie Starts JSW Steel Ltd. (JSTL) at Outperform
• UBS Starts Motilal Oswal Financial Services Ltd (MOFS:IN) at Buy